Inactive Ingredient Library 
Inactive ingredients refer to any components in a drug other than the active ingredient. They could be auxiliary substances added to pharmaceutical formulations to enhance the therapeutic effect of the drug by improving its characteristics, such as stability, solubility, and bioavailability, in order to better meet the needs of patients.
Inactive ingredients, or in this context, pharmaceutical excipients, have been used in approved drugs for specific routes of administration, therefore are typically no longer considered new ingredients. In practice, it can be assumed that the use of such ingredients is safe for use in a similar manner and type of product. When these inactive ingredients need to be incorporated into new drugs, less scrutiny may be required during the approval process.
The AnyMol Inactive Ingredient Library comprises 182 inactive ingredients from FDA-approved drugs, and is a valuable tool for drug development.
- All products & services are for research use only. Not for human or veterinary or therapeutic use.
- Pack Size
- 1 mg
- 10 μL x 10 mM (in DMSO)
- 30 μL x 10 mM (in DMSO)
- 50 μL x 10 mM (in DMSO)
- 100 μL x 10 mM (in DMSO)
Technical Information
Library Compound Information
Excel 
SDF - Product Description:
- A Collection of 182 inactive ingredients from FDA-approved drugs.
- Validated through preclinical research and clinical trials for biological activity and safety.
- Detailed documentation, including compound structures, target information, and activity descriptions.
- High purity ensured through NMR and HPLC detection techniques.
- All compounds are available in stock for immediate supply.
- Packaging And Storage:
- Powder or pre-dissolved DMSO solutions in 96/384 well plate with optional 2D barcode
- Shipped with blue ice
- This compound library is provided at a concentration of 10 mM in DMSO. A small number of compounds may be provided in different solvents or concentrations due to solubility or stability requirements. Please refer to the specific product information for details.
